Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Burkitt-Like Lymphoma With 11q Aberration · High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements · High Grade B-Cell Lymphoma, Not Otherwise Specified · Recurrent B Acute Lymphoblastic Leukemia · Recurrent Burkitt Lymphoma · Refractory B Acute Lymphoblastic Leukemia · Refractory Burkitt Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Elias Jabbour)
Study leads
Elias Jabbour, MD
Principal Investigator
M.D. Anderson Cancer Center